| Factor Information | |
|---|---|
| Data ID | 3830 |
| Factor | the frequency of hospital visits per patient-month after RF ablation |
| Description | After RF ablation, the frequencies of both reverted to levels higher than those observed during the baseline period 24 to 48 months before ablation (0.124 vs. 0.053 episodes of documented IART per patient-month, p = 0.004; 0.113 vs. 0.050 hospital visits per patient-month,p = 5 0.008). |
| Biomarker | NA |
| Classification | A12 (clinical factor - treatment) |
| Association | |
|---|---|
| Application | risk assessment |
| Objective | The objective of the study was to determine the early and midterm success rates of RF ablation in effecting a reduction of clinical arrhythmic events in patients with IART and CHD. |
| p Value | 0.008 |
| Conclusion | After RF ablation, the frequencies of both reverted to levels higher than those observed during the baseline period 24 to 48 months before ablation (0.124 vs. 0.053 episodes of documented IART per patient-month, p = 0.004; 0.113 vs. 0.050 hospital visits per patient-month,p = 5 0.008). |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 712 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | TOF, VSD/TGA/ASD/SV/CHD/other |
| Reference | |
|---|---|
| PMID | 9316535 |
| Year | 1997 |
| Title | Efficacy of Radiofrequency Ablation for Control of Intraatrial Reentrant Tachycardia in Patients With Congenital Heart Disease |
| Sample | ||
|---|---|---|
| Population | Adults | |
| Source | Clinical records | |
| Region | Massachusetts, USA. | |
| Method | analyzed retrospectively | |
| Race | North America | |
| Disease History | N/A | |
| Treatment History | VSD repair/ASD repair/unrepaired | |
| Group | patients with recurrence(Treatment) | patients with recurrence experience during the baseline period 24 to 48 months before ablation(Control) |
| Number | 7 | 12 |
| Age | 24.5 ± 10.5 years [range 7.9 to 44.8] | 24.5 ± 10.5 years [range 7.9 to 44.8] |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | 0.113 | 0.05 |
